key: cord-0050744-z57raijg authors: Forrest, Christopher B.; McTigue, Kathleen M.; Hernandez, Adrian F.; Cohen, Lauren W.; Cruz, Henry; Haynes, Kevin; Kaushal, Rainu; Kho, Abel N.; Marsolo, Keith A.; Nair, Vinit P.; Platt, Richard; Puro, Jon E.; Rothman, Russell L.; Shenkman, Elizabeth A.; Waitman, Lemuel Russell; Williams, Neely A.; Carton, Thomas W. title: PCORnet® 2020: Current State, Accomplishments, and Future Directions date: 2020-09-28 journal: J Clin Epidemiol DOI: 10.1016/j.jclinepi.2020.09.036 sha: c94ec7339b9244324c410e6af95587960331ffc5 doc_id: 50744 cord_uid: z57raijg OBJECTIVE: To describe PCORnet, a clinical research network developed for patient-centered outcomes research on a national scale. STUDY DESIGN AND SETTING: Descriptive study of the current state and future directions for PCORnet. We conducted cross-sectional analyses of the health systems and patient populations of the 9 Clinical Research Networks and 2 Health Plan Research Networks that are part of PCORnet. RESULTS: Within the Clinical Research Networks electronic health data are currently collected from 337 hospitals, 169,695 physicians, 3,564 primary care practices, 338 emergency departments, and 1,024 community clinics. Patients can be recruited for prospective studies from any of these clinical sites. The Clinical Research Networks have accumulated data from 80 million patients with at least 1 visit from 2009-2018. The PCORnet Health Plan Research Network population of individuals with a valid enrollment segment from 2009-2019 exceeds 60 million individuals, who on average have 2.63 years of follow-up. CONCLUSION: PCORnet’s infrastructure comprises clinical data from a diverse cohort of patients and has the capacity to rapidly access these patient populations for pragmatic clinical trials, epidemiological research, and patient-centered research on rare diseases. In 2013 the Patient-Centered Outcomes Research Institute (PCORI ® ) announced that it would fund the development of PCORnet ® , the National Patient-Centered Clinical Research Network (pcornet.org). The guiding vision was the formation of a national network-of-networks that engages patients, caregivers, clinicians, health system leaders, payers, and researchers in the design, conduct, and advancement of patient-centered outcomes research. 1 Partners would form a national infrastructure that could simultaneously support observational studies using electronic health record and health plan data while also conducting pragmatic clinical trials embedded within routine care settings. Both types of studies would generate new evidence that was timely, meaningful, and useful. 2, 3 The infrastructure supporting these activities would include institutional leadership leveraging a novel collaboration platform comprising comprehensive clinical data that is standardized, analysis-ready, and derived from medical institutions and health plans, common network and data governance, streamlined contracting and regulatory agreements, and resources for deeply engaging patients. 4 A large-scale consortium (i.e., a network-of-networks) with common administrative, technical, and governance resources and established health system partnerships would make research start-up, patient recruitment, and creation of large data-sets for observational research faster, easier, and more efficient than the status quo. PCORnet was developed on a bedrock of patient-centeredness, which is fundamental to all research funded by PCORI. 3 Patients are engaged in PCORnet's governance and research project leadership, conduct, and dissemination of results (HC and NAW are patient partners and coauthors of this manuscript). Partnering with stakeholders (i.e., patients, caregivers, clinicians, health system leaders, payers, and patient organizations) from the planning phase through the dissemination of research findings helps to ensure that the evidence generated by these studies is meaningful-that is, information that is useful for health-and healthcare-related decision-making and likely to be used. 5 11 ; and, various communication approaches that support prioritization of research topics. 12, 13 PCORnet is committed to developing the science of stakeholder engagement, using validated engagement tools, sharing effective processes, and scientifically evaluating both. The purpose of this manuscript is to take stock of PCORnet after several years of development. We present a calendar year 2020 snapshot of the current state of PCORnet's infrastructure, including organization and governance, data, and patient populations. We highlight some of the research studies conducted using PCORnet resources to illustrate the types of scientific inquiry the network-of-networks is well-suited for. The manuscript concludes with some future directions for PCORnet. The PCORnet network-of-network is governed by a 16-member Steering The primary data source for the PCORnet Clinical Research Networks is EHR data. An important limitation is that extant data are from health systems, and for some outcomes (e.g., myocardial infarction), there is incomplete ascertainment. PCORnet addresses this potential bias by linking the EHR data to health plan data to obtain complete capture of outcomes. Some data contributors maintain linked data sources, while others have regulatory agreements that enable linkage on a project-specific basis. About By the end of 2018, the PCORnet Clinical Research Network population totaled 80 million patients ( [Insert Table 3 About Here] The demographic distributions between the 10-year cohort and the 2018 cohort were similar. In general, patients seen more recently are more likely available to enroll into clinical studies. By developing trial selection criteria as queries developed in the SAS or SQL and using the common data model, investigators can identify consistent cohorts across the entire network to support more accurate trial design and execution of recruitment strategies. After networks and their sites complete a query against data obtained from patients seen in the past 18 months, they can be reidentified by the health systems (which hold reidentification keys); enabling a variety of techniques for rapidly recruiting participants into trials. This is a unique ability of the PCORnet infrastructure, and has been used successfully in ongoing clinical trials, such as ADAPTABLE, which is studying the optimal dosage of aspirin for secondary prevention of ischemic heart disease. 17 Table 4) . [Insert Table 4 About Here] Of the 10 common chronic conditions reported in The PCORnet Health Plan Research Network population totals over 60 million patients ( The PCORnet infrastructure is well-suited to facilitate the conduct of large-scale clinical trials. The diversity of clinical sites, common governance, and a common set of regulatory agreements enable PCORnet Network Partners to rapidly mount large pragmatic clinical trials, such as the NIH-sponsored PREVENTABLE trial, which will randomize 20,000 people over 75 years of age to statin or placebo to evaluate its effect on cardiovascular outcomes and cognitive decline. PCORnet Network Partners are also conducting the recently launched placebo-controlled HERO trial (Healthcare Worker Exposure Response & Outcomes--heroesresearch.org) that will evaluate whether hydroxychloroquine can prevent or attenuate COVID-19 illness in 15,000 healthcare workers. This study went from concept to first recruited patient in a matter of just a few weeks. With 80 million patients' electronic health record data stored in the Clinical Research Network databases and another 60 million patients in Health Plan Research Network databases, PCORnet comprises a rich set of resources for epidemiological, health services, and translational research on rare diseases (i.e., health conditions that affect fewer than 200,000 individuals in the US) or rare events (e.g., uncommonly occurring adverse events associated with medications, long-term effects of immunosuppressive agents). Clinical data from PCORnet Network Partners provides a rich resource for studying healthcare utilization, healthcare processes such as laboratory test orders and medication usage, and health outcomes such as laboratory results (e.g., hemoglobin A1C, low density lipoprotein, proteinuria), complications, and new diagnoses, both overall as well as patients with specific health conditions. When doing so, investigators, informaticians, and analysts work together to create code-sets from ICD-9-CM, ICD-10-CM, and SNOMED CT for health conditions, RxNorm for medications, CPT for procedures, and LOINC for lab results. Forming these code-sets, which may include in some cases thousands of codes, is an area of special expertise within PCORnet. The PCORnet Coordinating Center can deploy statistical queries of the network to rapidly return in a matter of days counts and descriptive statistics for patients with particular conditions or cohorts with various selection criteria to evaluate whether a study is feasible but also facilitate surveillance and observational studies for stakeholders. Investigators will be increasingly leveraging the PCORnet infrastructure for rare disease research to answer questions that are meaningful to patients affected by rare disease as well as their caregivers and clinicians. PCORnet Network Partners update their data every three months. However, at the time of the writing of this manuscript, the network is undertaking a national surveillance project to monitor rates of COVID-19 illness, testing, complications, and correlates. To accomplish this project, a subset of data related to COVID-19 illness is being updated on a weekly basis, taking advantage Launching PCORnet, a national patient-centered clinical research network Network news: powering clinical research PCORnet: turning a dream into reality Multistakeholder Engagement in PCORnet, the National Patient-Centered Clinical Research Network Getting engaged Patient and Stakeholder Engagement in the PCORI Pilot Projects: Description and Lessons Learned A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups Community Engagement Studios: A Structured Approach to Obtaining Meaningful Input From Stakeholders to Inform Research The development of a patient and caregiver narrative archive to support patient-centered research Strengthening Translational Research Through Citizen Scientist Education Engaging Stakeholders to Develop a Patient-centered Research Agenda: Lessons Learned From the Research Action for Health Network (REACHnet) Constituencies: Exploring Patient and Clinician Perspectives in the Age of Big Data Evaluating Foundational Data Quality in the National Patient-Centered Clinical Research Network Software-Enabled Distributed Network Governance: The PopMedNet Experience Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiol. 2020 Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health Role of health plan administrative claims data in participant recruitment for pragmatic clinical trials: An Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) example ) Gender, n (%) Male Female Other/missing 36 White Black/African-American Asian Native Hawaiian/Pacific Islander Other/Missing 49 Year of first visit, n (%) Health Conditions, n (%) Asthma Cancer Dementia Depression Epilepsy Heart failure Ischemic heart disease Osteoarthritis Stroke Type 2 diabetes mellitus 5